![]() |
市場調查報告書
商品編碼
2149611
2034年生物製造食品配料市場預測-按配料類型、生產平台、生物來源、食品類別、最終用戶和地區分類的全球分析Biomanufactured Food Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Production Platform, Biological Source, Food Category, End User, and Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球生物製造食品配料市場將達到 18 億美元,並在預測期內以 24.7% 的複合年成長率成長,到 2034 年達到 105 億美元。
生物製造食品配料是指利用微生物、培養細胞、酵素或發酵等生物系統生產的食品成分,而非僅依賴傳統的農業或化學生產方法。這些配料包括蛋白質、脂質、調味劑、酵素、色素、甜味劑、維生素以及其他用於食品和飲料配方的功能性化合物。製造商正在利用生物製造技術開發具有特定營養、功能、感官或永續性特徵的配料。其應用範圍涵蓋蛋白質替代品、機能性食品、飲料、烘焙產品、糖果甜點、乳製品替代品和營養補充品等。發酵、細胞培養、代謝工程和生物加工技術的進步正在拓展具有商業性價值的配料範圍。對永續和可擴展食品生產日益成長的需求正在推動市場發展。菌株工程、發酵效率、下游製程和生產規模的改進正在進一步提升生物製造食品配料的潛力。
市場動態
對永續和非動物性成分的需求日益成長
消費者和生產商對永續、低環境影響食品配料的需求日益成長,推動了生物製造食品配料的普及。生物製造技術無需依賴畜牧業即可生產與動物性來源同等的蛋白質和配料,從而顯著減少土地、水資源和溫室氣體排放。人們對傳統食品生產環境影響的認知不斷提高,也促進了市場擴張。消費者對不含動物性成分的產品的興趣日益濃厚,進一步推動了對生物製造配料的需求。企業對永續性的承諾正在加速食品飲料生產商對生物製造配料的採用。
生產成本高且難以擴大規模
生物製造食品配料的高昂生產成本嚴重阻礙了其與傳統配料的價格競爭。從實驗室規模到商業化生產的規模化生產面臨許多挑戰,影響生產的經濟效益和進度安排。有限的產能限制了產品開發和商業用途的供應。新食品配料的法規核准流程因地區而異,耗時較長。消費者對生物製造配料的接受度可能取決於加工方法及其新穎性認知。
生物製造平台創新
生物製造平台的創新為原料生產商帶來了巨大的成長機會。合成生物學的進步使得生產更複雜、產量更高的原料成為可能。開發經濟高效的生產平台增強了其相對於傳統原料的競爭力。增加對生物製造能力和技術的投資將加速商業化進程。原料生產商與食品生產商之間的合作將拓展其應用範圍。
與植物來源和傳統原料的競爭
來自植物來源蛋白質和傳統動物性原料的競爭可能會限制生物製造原料的普及。經濟壓力可能會阻礙食品生產商為永續原料支付更高的價格。影響新食品核准的監管變化可能會對市場發展產生連鎖反應。消費者對生物製造原料的懷疑態度可能會影響其普及化。生物製造的快速發展正在吸引新的參與者,並加劇競爭。
新冠感染疾病凸顯了傳統食品供應鏈的脆弱性,並加速了人們對生物製造作為更具韌性的生產方式的興趣。消費者對永續性和食品系統韌性的日益關注正在推動市場擴張。疫情後時期,對生物製造研發的投資增加。食品系統的轉型持續推動創新。消費者對替代蛋白的認知也不斷提高。
在預測期內,蛋白質細分市場預計將佔據最大的市場佔有率。
預計在預測期內,蛋白質領域將佔據最大的市場佔有率。這是因為蛋白質是生物製造食品配料中最有價值且應用最廣泛的類別。對替代蛋白日益成長的需求正在推動市場擴張。生物製造技術的進步使得生產功能性與傳統動物性蛋白質相當的蛋白質成為可能。完善的生產基礎設施和應用知識鞏固了該領域的領先地位。蛋白質已成為生物製造商業化過程中的重點。
在預測期內,精細發酵領域預計將呈現最高的複合年成長率。
在預測期內,微發酵領域預計將呈現最高的成長率,這主要得益於微發酵技術在多種食品配料生產中的日益普及。微發酵能夠生產高純度、高均勻性的特定功能性配料。發酵產能和技術的投資不斷增加,正在加速其商業化進程。消費者對微發酵配料的接受度持續提升。技術進步不斷提高生產效率並降低成本。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其強大的生物製造企業網路、先進的生物技術基礎設施以及對替代蛋白的早期應用。美國擁有許多具備成熟生產能力的大型生物製造企業。消費者對永續性的高度關注也推動了市場擴張。食品技術投資的不斷增加進一步鞏固了該地區的市場領先地位。
在預測期內,歐洲地區預計將呈現最高的複合年成長率,這主要得益於強力的監管支持(鼓勵永續食品創新)、企業積極主動的永續性舉措以及消費者意識的不斷提高。歐盟政策正在支持生物製造和新型食品的發展。大量的研究經費和企業投資正在推動相關技術的商業化。根深蒂固的永續性文化正在推動全部區域對生物製造原料的廣泛應用。
According to Stratistics MRC, the Global Biomanufactured Food Ingredients Market is accounted for $1.8 billion in 2026 and is expected to reach $10.5 billion by 2034 growing at a CAGR of 24.7% during the forecast period. Biomanufactured Food Ingredients are food components produced using biological systems such as microorganisms, cultured cells, enzymes, or fermentation-based processes rather than relying solely on conventional agricultural or chemical production methods. These ingredients can include proteins, fats, flavors, enzymes, pigments, sweeteners, vitamins, and other functional compounds used in food and beverage formulations. Manufacturers use biomanufacturing to develop ingredients with specific nutritional, functional, sensory, or sustainability characteristics. Applications span alternative proteins, functional foods, beverages, bakery products, confectionery, dairy alternatives, and nutritional products. Advances in fermentation, cell culture, metabolic engineering, and bioprocessing are expanding the range of commercially viable ingredients. Growing demand for sustainable and scalable food production is supporting market development. Improvements in strain engineering, fermentation efficiency, downstream processing, and production scale are further strengthening the potential of biomanufactured food ingredients.
Market Dynamics
Growing demand for sustainable, animal-free ingredients
Increasing consumer and manufacturer demand for sustainable food ingredients that reduce environmental impact is driving adoption of biomanufactured food ingredients. Biomanufacturing enables production of animal-identical proteins and ingredients without animal agriculture, significantly reducing land, water, and greenhouse gas footprints. Growing awareness of the environmental impact of conventional food production supports market expansion. Rising consumer interest in animal-free products drives demand for biomanufactured ingredients. Corporate sustainability commitments are accelerating adoption across food and beverage manufacturers.
High production costs and scale-up challenges
High production costs for biomanufactured food ingredients present significant barriers to price competitiveness with conventional ingredients. Scale-up challenges from laboratory to commercial production affect production economics and timelines. Limited production capacity constrains supply availability for product development and commercial applications. Regulatory approval processes for novel food ingredients vary across regions and can be lengthy. Consumer acceptance of biomanufactured ingredients may be affected by perceptions of processing and novelty.
Innovation in biomanufacturing platforms
Innovation in biomanufacturing platforms presents significant growth opportunities for ingredient manufacturers. Advances in synthetic biology enable production of increasingly complex ingredients with higher yields. Development of cost-effective production platforms improves competitiveness with conventional ingredients. Growing investment in biomanufacturing capacity and technology accelerates commercialization. Partnerships between ingredient companies and food manufacturers expand application possibilities.
Competition from plant-based and conventional ingredients
Competition from plant-based proteins and conventional animal-derived ingredients may limit adoption of biomanufactured ingredients. Economic pressures may affect food manufacturers' willingness to pay premiums for sustainable ingredients. Regulatory changes affecting novel food approval may impact market development. Consumer skepticism regarding biomanufactured ingredients may affect adoption. Rapid growth of biomanufacturing attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional food supply chains, accelerating interest in biomanufacturing as a resilient production method. Growing consumer focus on sustainability and food system resilience supports market expansion. The post-pandemic period has witnessed increased investment in biomanufacturing research and development. Food system transformation continues driving innovation. Consumer awareness of alternative proteins continues growing.
The proteins segment is expected to be the largest during the forecast period
The proteins segment is expected to account for the largest market share during the forecast period as proteins represent the most valuable and widely used category of biomanufactured food ingredients. Growing demand for alternative proteins drives market expansion. Advances in biomanufacturing enable production of proteins with functional properties matching conventional animal proteins. Established production infrastructure and application knowledge support segment leadership. Proteins are the primary focus of biomanufacturing commercialization.
The precision fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the precision fermentation segment is predicted to witness the highest growth rate driven by increasing adoption of precision fermentation for production of diverse food ingredients. Precision fermentation enables production of specific functional ingredients with high purity and consistency. Growing investment in fermentation capacity and technology accelerates commercialization. Consumer acceptance of precision-fermented ingredients continues growing. Technology advances continue improving production efficiency and reducing costs.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of biomanufacturing companies, advanced biotechnology infrastructure, and early adoption of alternative proteins. The United States hosts major biomanufacturing companies with established production capabilities. High consumer awareness of sustainability supports market expansion. Growing investment in food technology reinforces regional market leadership.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for sustainable food innovation, aggressive corporate sustainability commitments, and growing consumer awareness. European Union policies support biomanufacturing and novel food development. Significant research funding and corporate investment support technology commercialization. Strong sustainability culture drives adoption of biomanufactured ingredients across the region.
Key players in the market
Some of the key players in the Biomanufactured Food Ingredients Market include Perfect Day, Inc., The EVERY Company, Remilk Ltd., Shiru Inc., Helaina Inc., Clara Foods, Onego Bio, Formo Bio GmbH, Imagindairy Ltd., Change Foods, Planet A Foods, Bon Vivant, Melt&Marble, Mission Barns, and Uncommon Bio.
In September 2026, Perfect Day, Inc. launched a new biomanufactured dairy protein with enhanced functional properties for bakery and beverage applications, enabling improved texture and nutritional profiles.
In May 2026, The EVERY Company introduced a new biomanufactured egg protein for use in bakery and confectionery applications, offering functionality comparable to conventional egg whites.
In January 2026, Remilk Ltd. announced the expansion of its biomanufacturing production capacity to meet growing demand for animal-free dairy proteins in European markets.
In August 2025, Formo Bio GmbH launched a biomanufactured dairy protein specifically designed for cheese applications, enabling animal-free cheese production with authentic taste and texture.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.